Dong-A ST Co., Ltd. (KRX:170900)

Market Cap	418.09B
Revenue (ttm)	746.20B
Net Income (ttm)	-18.83B
Shares Out	9.16M
EPS (ttm)	-2,112.60
PE Ratio	n/a
Forward PE	20.25
Dividend	686.27 (1.50%)
Ex-Dividend Date	Mar 13, 2025

Volume	14,281
Average Volume	14,791
Open	45,450
Previous Close	45,300
Day's Range	45,100 - 46,250
52-Week Range	40,900 - 79,118
Beta	0.45
RSI	43.64
Earnings Date	Oct 30, 2025

About Dong-A ST

Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products in South Korea and internationally. It offers various ethical drugs, including Closerin Cap for active pulmonary and extra-pulmonary tuberculosis; Dulastin PFS and Leucostim injection/PFS to treat neutropenia in patients receiving myelosuppressive chemotherapy; Eporon inj./PFS for anemia associated with chronic renal failure; Gemcit inj. to treat non-small cell lung, pancreatic, breast, bladder, and ovarian cancers; Gonadopin inj./PFS for infertility and anovulation...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1932
• Employees: 1,679
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 170900